There is increasing evidence that intermittent hypoxia plays a role in the development of
cardiovascular risk in obstructive sleep apnoea syndrome (OSAS) through the activation of …

Obstructive sleep apnoea syndrome (OSAS) represents a highly prevalent disease and is
recognized as a risk factor for the development of various cardiovascular disorders. The …

Obstructive sleep apnoea syndrome (OSAS) is a highly prevalent disease and associated
with cardiovascular morbidity and mortality. The pathogenesis of cardiovascular …

Obstructive sleep apnoea syndrome (OSAS) is a highly prevalent disease and is recognised
as a major public health burden. Large-scale epidemiological studies have demonstrated an …

Obstructive sleep apnoea (OSA) is recognized as a major public health burden conveying a
significant risk of cardiovascular diseases (CVD) and mortality. Continuous positive airway …

Background—Obstructive sleep apnea syndrome (OSAS), characterized by intermittent
hypoxia/reoxygenation (IHR), is an independent risk factor for cardiovascular disease. We …

Obstructive sleep apnea syndrome (OSAS), which is a highly prevalent breathing disorder in
sleep, is an independent risk factor for cardiovascular morbidity and mortality. Results from …

The pathogenesis of cardiovascular complications in obstructive sleep apnea syndrome
(OSAS) is not fully understood but is likely multifactorial in origin. Inflammatory processes …

Obstructive sleep apnoea syndrome is a growing health concern, affecting nearly one billion
people worldwide; it is an independent cardiovascular risk factor, associated with incident …

Obstructive sleep apnea results in intermittent hypoxia via repetitive upper airway
obstruction leading to partial or complete upper airway closure, apneas and hypopneas …